High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial: Background, Aims, and Study Protocol

BACKGROUND: Hypoxic ischemic encephalopathy (HIE) remains an important cause of neonatal death and frequently leads to significant long-term disability in survivors. Therapeutic hypothermia, while beneficial, still leaves many treated infants with lifelong disabilities. Adjunctive therapies are need...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neonatology
Autores principales: Juul, Sandra E., Comstock, Bryan A., Heagerty, Patrick J., Mayock, Dennis E., Goodman, Amy M., Hauge, Stephanie, Gonzalez, Fernando, Wu, Yvonne W.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5980685/
https://ncbi.nlm.nih.gov/pubmed/29514165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000486820
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares